[go: up one dir, main page]

UY27139A1 - A SUSPENSION THAT INCLUDES FIBRINOGEN, THROMBIN AND ALCOHOL, A PROCEDURE TO PREPARE SUCH SUSPENSION, A PROCEDURE TO COVER A SUPPORT WITH SUCH SUSPENSION, A DRYING PROCEDURE FOR A COVER OF A SUPPORT, AND A SPONGE - Google Patents

A SUSPENSION THAT INCLUDES FIBRINOGEN, THROMBIN AND ALCOHOL, A PROCEDURE TO PREPARE SUCH SUSPENSION, A PROCEDURE TO COVER A SUPPORT WITH SUCH SUSPENSION, A DRYING PROCEDURE FOR A COVER OF A SUPPORT, AND A SPONGE

Info

Publication number
UY27139A1
UY27139A1 UY27139A UY27139A UY27139A1 UY 27139 A1 UY27139 A1 UY 27139A1 UY 27139 A UY27139 A UY 27139A UY 27139 A UY27139 A UY 27139A UY 27139 A1 UY27139 A1 UY 27139A1
Authority
UY
Uruguay
Prior art keywords
suspension
support
procedure
thrombin
cover
Prior art date
Application number
UY27139A
Other languages
Spanish (es)
Inventor
Alfred Schaufler
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of UY27139A1 publication Critical patent/UY27139A1/en

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una suspensión de fibrinogeno, trombina, alcohol y opcionalmente aprotinina se obtiene mezclando fibrinogeno en alcohol con trombina en alcohol. La suspensión contiene partículas de fibrinogeno y de trombina con un diámetro medio Folk Ward de 25-100m. La trombina puede ser humana, bovina o recombinante. El fibrinogeno puede ser humano o recombinante. Se describe un método para revestir un soporte, tal como una esponja de colágeno, con la suspensión, y un método para secar el revestimiento. El soporte revestido con colágeno puede ser utilizado como una composición absorbible, lista para usar, para pegar tejidos, cerrar tejidos y para hemostasis, en donde el soporte está revestido con componentes fijados firmemente de adhesivos de fibrina, es decir, fibrinogeno y trombina.A suspension of fibrinogen, thrombin, alcohol and optionally aprotinin is obtained by mixing fibrinogen in alcohol with thrombin in alcohol. The suspension contains fibrinogen and thrombin particles with an average Folk Ward diameter of 25-100m. The thrombin can be human, bovine or recombinant. The fibrinogen can be human or recombinant. A method of coating a support, such as a collagen sponge, with the suspension, and a method of drying the coating is described. The collagen-coated support can be used as an absorbable, ready-to-use composition for gluing tissues, closing tissues and for hemostasis, wherein the support is coated with firmly fixed components of fibrin adhesives, that is, fibrinogen and thrombin.

UY27139A 2001-01-25 2002-01-25 A SUSPENSION THAT INCLUDES FIBRINOGEN, THROMBIN AND ALCOHOL, A PROCEDURE TO PREPARE SUCH SUSPENSION, A PROCEDURE TO COVER A SUPPORT WITH SUCH SUSPENSION, A DRYING PROCEDURE FOR A COVER OF A SUPPORT, AND A SPONGE UY27139A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100135 2001-01-25

Publications (1)

Publication Number Publication Date
UY27139A1 true UY27139A1 (en) 2002-08-30

Family

ID=34560110

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27139A UY27139A1 (en) 2001-01-25 2002-01-25 A SUSPENSION THAT INCLUDES FIBRINOGEN, THROMBIN AND ALCOHOL, A PROCEDURE TO PREPARE SUCH SUSPENSION, A PROCEDURE TO COVER A SUPPORT WITH SUCH SUSPENSION, A DRYING PROCEDURE FOR A COVER OF A SUPPORT, AND A SPONGE

Country Status (4)

Country Link
EC (1) ECSP034747A (en)
UA (2) UA74046C2 (en)
UY (1) UY27139A1 (en)
ZA (3) ZA200305592B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112891610A (en) * 2021-01-25 2021-06-04 上海利康瑞生物工程有限公司 Pig-derived fibrin-electrostatic spinning nanofiber antibacterial hemostatic patch and preparation method thereof

Also Published As

Publication number Publication date
ZA200305592B (en) 2004-10-18
ZA200305588B (en) 2004-10-18
UA74045C2 (en) 2005-10-17
UA74046C2 (en) 2005-10-17
ZA200305591B (en) 2004-10-18
ECSP034747A (en) 2004-01-28

Similar Documents

Publication Publication Date Title
AR032800A1 (en) A SUSPENSION THAT INCLUDES FIBRINOGEN, THROMBIN AND ALCOHOL, A METHOD FOR PREPARING SUCH SUSPENSION, A METHOD FOR COVERING AN AGENT WITH SUCH SUSPENSION, AND A METHOD FOR DRYING A COVER OF AN AGENT, AND A COLOGEN COVER
NO20002357D0 (en) Fibrin sealant or adhesive comprising a hyaluronic acid derivative material
BR0115576A (en) Biocompatible Adhesives
CA2295247A1 (en) Compositions containing thrombin and microfibrillar collagen
BRPI0613811B8 (en) use of allogeneic stromal stem cells derived from adipose tissue
TW200621320A (en) Adhesive composition
AU2016204344A1 (en) Improved methods and compositions for wound healing
DE50005818D1 (en) SPRAYABLE BONE REPLACEMENT MATERIAL CONTAINING FIBRINE OR FIBRINOGEN AND HYDROXYLAPATITE CEMENT
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
GB2348426A (en) Enzyme-mediated modification of fibrin for tissue engineering
IL163439A (en) Compositions comprising embryonic-like stem cells derived from post-partum mammalian placenta and human stem or progenitor cells and kits comprising such compositions
WO2003099344A3 (en) Skin adhesive for cushions and wound dressings
CL2008001171A1 (en) Pharmaceutical composition comprising fibrinogen, thrombin and a compound containing strontium; and its use in the treatment of a diseased, damaged, deficient or defective bone.
WO2008019128A3 (en) Solid dressing for treating wounded tissue
ATE309006T1 (en) SPRAY DEVICE FOR APPLYING FABRIC ADHESIVE
BRPI0519170A8 (en) human growth hormone formulations comprising an unnaturally encoded amino acid
DE60232234D1 (en) METHOD OF CULTURING CIRCOVIRUS
BRPI0613123B8 (en) cellless graft
MY162181A (en) Compositions and methods for modulating hemostasis
ATE507855T1 (en) TRANSGLUTAMINASE CROSS-LINKED COLLAGEN BIOMATERIAL FOR MEDICAL IMPLANTATION MATERIALS
ATE318608T1 (en) SPRAY ADMINISTRATION OF CELLS
ATE547130T1 (en) BIOCOMPATIBLE IMPLANT
UY25700A1 (en) MEDICINAL IMPLANTS COATED WITH POLYMERS OR A MIXTURE OF POLYMERS, STERILE SOLUTION CONTAINING SUCH POLYMERS AND THE USE OF THEM, AND PROCEDURES FOR THE PREPARATION OF THESE IMPLANTS
WO2006093860A3 (en) Method and composition for repairing heart tissue
EP4470628A3 (en) Fragrance release mechanism, method and uses thereof

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150715